Целесообразность применения L-аргинина в терапии недостаточности лютеиновой фазы у пациенток репродуктивного возраста

Author: Потапов В.А.
ГУ «Днепропетровская медицинская академия»
Published: Здоров’я України. Тематический номер №2/2016

Целесообразность применения L-аргинина в терапии недостаточности лютеиновой фазы у пациенток репродуктивного возраста

Sorry, this entry is only available in Russian and Ukrainian.

Last Publication:

The role of L-arginine in the treatment of cardiovascular diseases: the focus is on the choice of effective dose

L-arginine is a conditionally essential amino acid that was first isolated in 1886 by E. Schulze and E. Steiger, and its structure was established by E. Schulze and E. Winterstei in 1897 [1]. L-arginine is used several times ways for the synthesis of protein and low molecular weight bioactive substances (eg, nitric oxide – NO, ornithine, proline, creatine and polyamines), which are of great physiological importance.